These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 29753882)
21. Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC. Mascalchi M; Falchini M; Maddau C; Salvianti F; Nistri M; Bertelli E; Sali L; Zuccherelli S; Vella A; Matucci M; Voltolini L; Pegna AL; Luconi M; Pinzani P; Pazzagli M J Cancer Res Clin Oncol; 2016 Jan; 142(1):195-200. PubMed ID: 26210156 [TBL] [Abstract][Full Text] [Related]
22. Circulating tumor cells in whole process management of gastrointestinal stromal tumor in a real-life setting. Zhang Q; Xu K; Chen M; Miao Y; Wang N; Xu Z; Xu H Saudi J Gastroenterol; 2020; 26(3):160-167. PubMed ID: 32386192 [TBL] [Abstract][Full Text] [Related]
23. Looking back, to the future of circulating tumor cells. Friedlander TW; Premasekharan G; Paris PL Pharmacol Ther; 2014 Jun; 142(3):271-80. PubMed ID: 24362084 [TBL] [Abstract][Full Text] [Related]
24. CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs). Tayoun T; Faugeroux V; Oulhen M; Aberlenc A; Pawlikowska P; Farace F Cells; 2019 Sep; 8(10):. PubMed ID: 31557946 [TBL] [Abstract][Full Text] [Related]
25. Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology. Ma YC; Wang L; Yu FL Technol Cancer Res Treat; 2013 Aug; 12(4):295-309. PubMed ID: 23448577 [TBL] [Abstract][Full Text] [Related]
26. Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment. Donato C; Szczerba BM; Scheidmann MC; Castro-Giner F; Aceto N J Vis Exp; 2019 May; (147):. PubMed ID: 31157780 [TBL] [Abstract][Full Text] [Related]
27. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer. Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836 [TBL] [Abstract][Full Text] [Related]
28. Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer. Liu M; Tang M; Li M; Gao F; Shi C; Hou J; Zeng W Anticancer Agents Med Chem; 2016; 16(12):1529-1540. PubMed ID: 26902602 [TBL] [Abstract][Full Text] [Related]
29. Research progress on the multi-omics and survival status of circulating tumor cells. Xie Q; Liu S; Zhang S; Liao L; Xiao Z; Wang S; Zhang P Clin Exp Med; 2024 Mar; 24(1):49. PubMed ID: 38427120 [TBL] [Abstract][Full Text] [Related]
30. The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment. Hao YJ; Chang LW; Yang CY; Lo LC; Lin CP; Jian YW; Jiang JK; Tseng FG Transl Res; 2024 Jan; 263():1-14. PubMed ID: 37558203 [TBL] [Abstract][Full Text] [Related]
31. Circulating tumor cells: a multifunctional biomarker. Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278 [TBL] [Abstract][Full Text] [Related]
32. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer. Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320 [TBL] [Abstract][Full Text] [Related]
33. Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis. Tadimety A; Syed A; Nie Y; Long CR; Kready KM; Zhang JX Integr Biol (Camb); 2017 Jan; 9(1):22-49. PubMed ID: 27929582 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of circulating tumor cells and analysis of clinicopathological factors in liver cancer. Cui K; Ou Y; Ning D; Li H; Xi Y; Li S J Cancer Res Ther; 2022 Apr; 18(2):452-460. PubMed ID: 35645114 [TBL] [Abstract][Full Text] [Related]
35. A Preliminary Analysis of Circulating Tumor Microemboli from Breast Cancer Patients during Follow-Up Visits. Lai HC; Huang HH; Hao YJ; Lee HL; Wang CC; Ling TY; Wu JK; Tseng FG Curr Oncol; 2024 Sep; 31(9):5677-5693. PubMed ID: 39330049 [TBL] [Abstract][Full Text] [Related]
36. Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma. Chang MC; Chang YT; Chen JY; Jeng YM; Yang CY; Tien YW; Yang SH; Chen HL; Liang TY; Wang CF; Lee EY; Chang YC; Lee WH Clin Chem; 2016 Mar; 62(3):505-13. PubMed ID: 26861552 [TBL] [Abstract][Full Text] [Related]
37. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice. Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364 [TBL] [Abstract][Full Text] [Related]